Australia-based Gelteq has announced the establishment of a new Gelteq Centre of Excellence in Guangdong Province, China. The Gelteq Centre of Excellence will serve as a strategic regional hub enabling deeper integration with and strategic access to one of the world’s fastest-growing pharmaceutical and biotechnology ecosystems.
The establishment of Gelteq’s Guangdong Province-based Centre of Excellence will strengthen the company’s globally integrated development platform by leveraging regional infrastructure, technical expertise, and established innovation networks.
The hub is expected to support accelerated product development and commercialisation timelines; expanded formulation, testing, and product optimisation capabilities; increased capacity to advance multiple development programmes simultaneously.
This strategy aligns with approaches adopted by leading global pharmaceutical and biotechnology companies that utilise regional innovation hubs to improve scalability, operational efficiency, and development execution across global pipelines.
Gelteq is a biotechnology company that has developed a novel drug delivery platform in an ingestible gel form.
